A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome

Journal of Urology

Volumn 171, Issue 1, 2004, Pages 284-288

  Kaplan, Steven A ^a,c   Volpe, Michael A ^a   Te, Alexis E ^b  

^a Coll Phys/Surgs Columbia Univ ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Irving Pavilion ^*  (United States)

Author keywords

Finasteride; Prostatitis; Serenoa

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; FINASTERIDE; SABAL EXTRACT;

ADULT; ARTICLE; CHRONIC PROSTATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY;

EID: 0347479284     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000101487.83730.80     Document Type: Article

References (20)

1. Nickel, J. C.: Prostatitis: myths and realities. Urology, 51: 362, 1998
2. McNaughton Collins, M., Stafford, R. S., O'Leary, M. P. and Barry, M. J.: How common is prostatitis? A national survey of physician visits. J Urol, 159: 1224, 1998
3. Nickel, J. C., Downey, J., Hunter, D. and Clark, J.: Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol, 165: 842, 2001
4. Nickel, J. C.: Effective office management of chronic prostatitis. Urol Clin North Am, 25: 677, 1998
5. Shoskes, D. A.: Phytotherapy and other alternative forms of care for the patient with prostatitis. Curr Urol Rep, 3: 330, 2002
6. Leskinen, M., Lukkarinen, O. and Marttila, T.: Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study. Urology, 53: 502, 1999
7. Ruggendorff, E. W., Weidner, W., Ebeling, L. and Buck, A. C.: Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol, 71: 433, 1993
8. Shoskes, D. A., Zeitlin, S. I., Shahed, A. and Rajfer, J.: Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology, 54: 960, 1999
9. Marks, L. S., Partin, A. W., Epstein, J. I., Tyler, V. E., Simon, I., Macairan, M. L. et al: Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol, 163: 1451, 2000
10. Paubert-Braquet, M., Mencia Huerta, J. M., Cousse, H. and Braquet, P.: Effect of lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils. Prostaglandins Leukot Essent Fatty Acids, 57: 299, 1997
11. McConnell, J. D., Bruskewitz, R., Walsh, P., Andriole, G., Lieber, M., Holtgrewe, H. L. et al: The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med, 338: 557, 1998
12. Probert, K. J., Alexander, R. B., Nickel, J. C., Kusek, J. W., Litwin, M. S., Landis, J. R. et al: Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology, 59: 870, 2002
13. Guardia, T., Rotelli, A. E., Juarez, A. O. and Pelzer, L. E.: Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hespiridin on adjuvant arthritis in rats. Farmaco, 56: 683, 2001
14. Plosker, G. L. and Brogden, R. N.: Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging, 9: 379, 1996
15. Weisser, H., Tunn, S., Behnke, B. and Krieg, M.: Effects of sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia. Prostate, 28: 300, 1996
16. Wilt, T. J., Ishani, A., Stark, G., MacDonald, R., Lau, J. and Mulrow, C.: Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA, 280: 1604, 1998
17. Russell, D. W. and Wilson, J. D.: Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem, 63: 25, 1994
18. Rhodes, L., Primka, R. L., Berman, C., Vergult, G., Gabriel, M., Pierre-Malice, M. et al: Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition. Prostate, 22: 43, 1993
19. Marshall, S. and Narayan, P.: Treatment of prostatic bleeding: suppression of angiogenesis by androgen deprivation. J Urol, 149: 1553, 1993
20. Bailey, D. M., Foley, S. J. and Wedderburn, A.: Effect of finasteride on microvessel density (MVD) in patients with recurrent haematuria related to prostatic hypertrophy (BPH). J Urol, suppl., 161: 363, abstract 1406, 1999